Hangzhou woman has been bleeding from her chest for more than half a year, and the doctor reminds: Be careful of this cancer
Time of Update: 2022-11-01
Aunt Wang of Hangzhou City, Zhejiang Province, waited early in the morning at the breast surgeon's office of the Municipal Red Cross Hospital, and when she saw Dr. Su Yanyan, she hurriedly greeted he
This gene is mutated in more than 50% of cancers! One article to understand the different strategies to overcome
Time of Update: 2022-10-20
Since most TP53 gene mutations cause p53 inactivation, the use of gene therapy to express p53 with normal function is also an important research and development direction to restore p53 function.
Annual Inventory Summary of Peripheral T-Cell Lymphoma Progress in 2021
Time of Update: 2022-03-09
Dehui Zou: Analysis of Clinical Characteristics and Efficacy of Peripheral T-cell LymphomaProfessor Zhang Liling at the 6th Anti-Leukemia and Lymphoma International Summit Forum with the title of "New Progress and Practice Sharing of Targeted Therapy for Peripheral T-cell Lymphoma", In-depth discussions were conducted in three aspects: "current status of peripheral T-cell lymphoma (PTCL) treatment", "optimization of initial treatment regimens", and "exploration of relapsed and refractory regimens" .
CStone Announces the Announcement of the Results of the Phase IV Non-Small Cell Lung Cancer Registration Clinical Study Results of Zejimay(R) (Sugelimumab Injection) in The Lancet-Oncology
Time of Update: 2022-01-23
15, 2022 /PRNewswire/ -- CStone Pharmaceuticals (SEHK: 2616), a leading biopharmaceutical company focusing on the research, development and commercialization of innovative immuno-oncology and precision medicines, today Announced that The Lancet Oncology , the world's leading clinical oncology research journal, published online a randomized trial of Zejimet® (sugalimab injection) in the first-line treatment of stage IV non-small cell lung cancer (NSCLC).
Alzheimers & Dementia: Investigating the relationship between cancer and dementia risk
Time of Update: 2021-11-13
found in a large prospective community cohort study that cancer has been determined by several epidemiological studies to have a protective effect on dementia, especially Alzheimer’s disease (AD) .
J Clin Oncol: Health-related quality of life in Patients with Hodgkin's Lymphoma for 5 Years (HRQoL
Time of Update: 2020-07-13
Health-related quality of life (HRQoL) refers to the determination of subjective health status and individual satisfaction associated with individual life events under the influence of disease, acci
Top 20 forecast of potential blockbuster drug sales in R & D line of pharmaceutical industry
Time of Update: 2014-08-05
Source: dingxiangyuan 2014-08-05 based on the current consensus forecast, the top 20 drugs under research in the pharmaceutical industry will generate about $40 billion in global sales by 2020 By the